Get free PhD updates, every week | SIGN UP NOW Get free PhD updates, every week | SIGN UP NOW

We have 8 Cancer Biology PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Belfast

Discipline

Discipline

Biological Sciences

Location

Location

Belfast  United Kingdom

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


Cancer Biology PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Belfast

We have 8 Cancer Biology PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships in Belfast

A PhD in Cancer Biology would provide you with the opportunity to research a specific cancer in great detail. Whether you’re developing a new treatment, understanding the factors that allow a tumour to arise or innovating better diagnostic tests, you’ll be improving our understanding of cancer and saving lives.

What’s it like to do a PhD in Cancer Biology?

Doing a PhD in Cancer Biology, you’ll develop excellent laboratory skills, particularly in cell culture, working with RNA and studying the proteome. Most Cancer Biology projects link to other subjects and as such, you’ll have experience working with techniques from Cell Biology, Immunology and Genetics.

Some typical research topics in Cancer Biology include:

  • Developing novel diagnostic tests
  • Understanding a potential trigger of metastasis
  • Developing novel therapeutics to treat a specific cancer
  • The immune system and cancer interactions
  • Characterising the role of a specific tumour suppressor or oncogene in a certain cancer

Generally, Cancer Biology programmes are advertised on the university website with the research proposal, including the scope and primary aim of the research pre-determined by the supervisor. These projects are usually fully-funded.

It’s uncommon to propose your own research in Cancer Biology since the additional bench fees make self-funding difficult. It can also be tricky to find a supervisor with the interests that line up well with your suggested project that also have the equipment and expertise to supervise you through your PhD.

In your daily life you’ll be in the laboratory conducting experiments, reading the literature for new methods you could try, analysing old data, and talking to colleagues and your supervisor about your work. In the final year of your PhD you’ll submit a thesis of around 60,000 words that will contribute to the knowledge of your field and you’ll defend your work during your viva exam.

Entry requirements

The entry requirements for most Cancer Biology PhD programmes involve a Masters in a subject directly related to Biology, with at least a Merit or Distinction. If English isn’t your first language, you’ll also need to show that you have the right level of language proficiency.

PhD in Cancer Biology funding options

The Research Council responsible for funding Cancer Biology PhDs in the UK is the Biotechnology and Biological Sciences Research Council (BBSRC). They provide fully-funded studentships including a stipend for living costs, a consumables budget for bench fees and a tuition fee waiver. Students don’t apply directly to the BBSRC, you apply for advertised projects with this funding attached.

It’s uncommon for Cancer Biology PhD students to be ‘self-funded’ due to the additional bench fees. However, if you were planning to fund yourself it might be achievable (depending on your project) through the UK government’s PhD loan and part-time work.

read more
PhD saved successfully

Investigating the clinical and molecular significance of the microbiome in breast cancer

Breast Cancer (BC) is the most common cancer in the UK, accounting for 15% of new cancer cases. There is a significant unmet clinical need to understand why some cancers do not respond to treatment and what drives metastasis. Read more

Dissecting mechanism of drug responses to novel anti-cancer therapies

Repurposing drug screens with compounds that have already gained FDA approval can accelerate the identification of new therapies to treat an illness and in the cancer setting extend life or provide compassionate care. Read more

Assessing the molecular mechanisms by which Cathepsin V promotes breast cancer growth and metastasis

Targeted therapies such as tamoxifen, fulvestrant and anastrozole have exhibited significant clinical success since being introduced as treatments for Estrogen Receptor positive (ER+) breast cancer patients. Read more

Investigating the role of USP17 in EMT

USP17 is over-expressed in a range of primary tumours (NSCLC, breast, colorectal, cervical, ovarian, osteosarcoma) and its depletion blocks the growth, and migration, of cells from all of these cancer types. Read more

Countering the proteinase-activated receptor 1 (PAR-1) pro-tumour phenotype using a novel nanotherapeutic approach

Proteinase-activated receptor 1 (PAR1) is a G-protein coupled receptor (GPCR) expressed on a number of cell types, and is activated by serine proteases such as thrombin, plasmin and activated protein C. Read more

Safer, scalable, and modifiable polymer-based lipid nanocapsules for drug delivery

Lipid nanocapsules (LNCs) are very interesting nanoformulations as they can be made by phase inversion technique (PIT), a scalable method with predictable particle size at the beginning of the preparation process. Read more

Self-Navigating Nanocarriers for Intracellular Protein Delivery

Protein-based therapeutics have shown remarkable success in modulating extracellular targets; however, effective intracellular delivery remains a key challenge in biotherapeutics. Read more

Development of a multi-antigenic mRNA vaccine for Glioblastoma

Glioblastoma is an aggressive brain tumour with the median survival time of ~15 months and the 5 year survival rates for those over 50 at a mere 6% (American Cancer Society). Read more
  • 1

Filtering Results